Cargando…

Mechanism and therapeutic strategy of hepatic TM6SF2-deficient non-alcoholic fatty liver diseases via in vivo and in vitro experiments

BACKGROUND: The lack of effective pharmacotherapies for nonalcoholic fatty liver disease (NAFLD) is mainly attributed to insufficient research on its pathogenesis. The pathogenesis of TM6SF2-efficient NAFLD remains unclear, resulting in a lack of therapeutic strategies for TM6SF2-deficient patients....

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Zu-Yin, Wu, Gang, Qiu, Chen, Zhou, Zhi-Jie, Wang, Yu-Peng, Song, Guo-He, Xiao, Chao, Zhang, Xin, Deng, Gui-Long, Wang, Rui-Tao, Yang, Yu-Long, Wang, Xiao-Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Basic Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280743/ https://www.ncbi.nlm.nih.gov/pubmed/35978872 http://dx.doi.org/10.3748/wjg.v28.i25.2937

Ejemplares similares

TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease
por: Liu, Yang-Lin, et al.
Publicado: (2014)

Myeloid TM6SF2 Deficiency Inhibits Atherosclerosis
por: Zhu, Wenzhen, et al.
Publicado: (2022)

Additive Effects of the Risk Alleles of PNPLA3 and TM6SF2 on Non-alcoholic Fatty Liver Disease (NAFLD) in a Chinese Population
por: Wang, Xiaoliang, et al.
Publicado: (2016)

Disruption of the ERLIN–TM6SF2–APOB complex destabilizes APOB and contributes to non-alcoholic fatty liver disease
por: Li, Bo-Tao, et al.
Publicado: (2020)

TM6SF2 E167K variant predicts severe liver fibrosis for human immunodeficiency/hepatitis C virus co-infected patients, and severe steatosis only for a non-3 hepatitis C virus genotype
por: Sagnelli, Caterina, et al.
Publicado: (2016)

TM4SF1 Promotes Gemcitabine Resistance of Pancreatic Cancer In Vitro and In Vivo
por: Cao, Jia, et al.
Publicado: (2015)

Three Members of Transmembrane-4-Superfamily, TM4SF1, TM4SF4, and TM4SF5, as Emerging Anticancer Molecular Targets against Cancer Phenotypes and Chemoresistance
por: Rahim, Nur Syafiqah, et al.
Publicado: (2023)

Clinical significance of TM4SF1 as a tumor suppressor gene in gastric cancer
por: Peng, Xing‐Chun, et al.
Publicado: (2018)

Down-regulation of TM4SF is associated with the metastatic potential of gastric carcinoma TM4SF members in gastric carcinoma
por: Chen, Zhouxun, et al.
Publicado: (2011)

Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease
por: Yang, Jia-Min, et al.
Publicado: (2019)

Fibrinogen-like protein 2 deficiency inhibits virus-induced fulminant hepatitis through abrogating inflammatory macrophage activation
por: Xiao, Fang, et al.
Publicado: (2022)

TM4SF5-mediated abnormal food-intake behavior and apelin expression facilitate non-alcoholic fatty liver disease features
por: Pinanga, Yangie Dwi, et al.
Publicado: (2023)

TM4SF1 Promotes Proliferation, Invasion, and Metastasis in Human Liver Cancer Cells
por: Huang, Yu-Kun, et al.
Publicado: (2016)

miR-192-5p regulates lipid synthesis in non-alcoholic fatty liver disease through SCD-1
por: Liu, Xiao-Lin, et al.
Publicado: (2017)

PNPLA3 and TM6SF2 polymorphisms in Brazilian patients with nonalcoholic fatty liver disease
por: Lisboa, Quelson Coelho, et al.
Publicado: (2020)

TM6SF2: A Novel Genetic Player in Nonalcoholic Fatty Liver and Cardiovascular Disease
por: Luo, Fei, et al.
Publicado: (2021)

Targeting TM4SF5 with anti-TM4SF5 monoclonal antibody suppresses the growth and motility of human pancreatic cancer cells
por: Park, Sangkyu, et al.
Publicado: (2020)

Mismatched effects of receptor interacting protein kinase-3 on hepatic steatosis and inflammation in non-alcoholic fatty liver disease
por: Saeed, Waqar Khalid, et al.
Publicado: (2018)

Integrated network analysis of transcriptomic and protein-protein interaction data in taurine-treated hepatic stellate cells
por: Liang, Xing-Qiu, et al.
Publicado: (2019)

Mesencephalic astrocyte-derived neurotrophic factor ameliorates steatosis in HepG2 cells by regulating hepatic lipid metabolism
por: He, Miao, et al.
Publicado: (2020)

In vivo recognition of bioactive substances of Polygonum multiflorum for protecting mitochondria against metabolic dysfunction-associated fatty liver disease
por: Yu, Li-Ping, et al.
Publicado: (2023)

Ubiquitin-specific protease 22 enhances intestinal cell proliferation and tissue regeneration after intestinal ischemia reperfusion injury
por: Ji, An-Long, et al.
Publicado: (2019)

Anti-cancer Activity of Novel TM4SF5-Targeting Antibodies through TM4SF5 Neutralization and Immune Cell-Mediated Cytotoxicity
por: Ahn, Hye-Mi, et al.
Publicado: (2017)

Crosstalk between TM4SF5 and GLUT8 regulates fructose metabolism in hepatic steatosis
por: Lee, Hyejin, et al.
Publicado: (2022)

Association of TM6SF2 rs58542926 gene polymorphism with the risk of non-alcoholic fatty liver disease and colorectal adenoma in Chinese Han population
por: Li, Yuan, et al.
Publicado: (2019)

TM4SF1 Promotes Metastasis of Pancreatic Cancer via Regulating the Expression of DDR1
por: Yang, Jia-chun, et al.
Publicado: (2017)

The Tm7sf2 Gene Deficiency Protects Mice against Endotoxin-Induced Acute Kidney Injury
por: Gatticchi, Leonardo, et al.
Publicado: (2015)

TM9SF4 Is a Crucial Regulator of Inflammation and ER Stress in Inflammatory Bowel Disease
por: Xie, Mingxu, et al.
Publicado: (2022)

Green tea polyphenols ameliorate non-alcoholic fatty liver disease through upregulating AMPK activation in high fat fed Zucker fatty rats
por: Tan, Yi, et al.
Publicado: (2017)

Fecal microbiota transplantation prevents hepatic encephalopathy in rats with carbon tetrachloride-induced acute hepatic dysfunction
por: Wang, Wei-Wei, et al.
Publicado: (2017)

Combined effects of PNPLA3, TM6SF2 and HSD17B13 variants on severity of biopsy-proven non-alcoholic fatty liver disease
por: Paternostro, Rafael, et al.
Publicado: (2021)

PNPLA3, TM6SF2, and MBOAT7 Influence on Nutraceutical Therapy Response for Non-alcoholic Fatty Liver Disease: A Randomized Controlled Trial
por: Dallio, Marcello, et al.
Publicado: (2021)

Hepatic TM6SF2 Is Required for Lipidation of VLDL in a Pre-Golgi Compartment in Mice and Rats
por: Luo, Fei, et al.
Publicado: (2021)

TM4SF5-Mediated Roles in the Development of Fibrotic Phenotypes
por: Ryu, Jihye, et al.
Publicado: (2017)

TM9SF1 knockdown decreases inflammation by enhancing autophagy in a mouse model of acute lung injury
por: Xiao, Juan, et al.
Publicado: (2022)

Antiviral effects of hepatitis B virus S gene-specific anti-gene locked nucleic acid in transgenic mice
por: Xiao, Shu-Rong, et al.
Publicado: (2018)

TM6SF2 rs58542926 is related to hepatic steatosis, fibrosis and serum lipids both in adults and children: A meta-analysis
por: Li, Xue-Ying, et al.
Publicado: (2022)

Failure of carnitine in improving hepatic nitrogen content in alcoholic and non‐alcoholic malnourished rats
por: Rodrigues, Luciana P, et al.
Publicado: (2010)

Feasibility and efficacy evaluation of metallic biliary stents eluting gemcitabine and cisplatin for extrahepatic cholangiocarcinoma
por: Xiao, Jing-Bo, et al.
Publicado: (2020)

TM4SF1 promotes the self-renewal of esophageal cancer stem-like cells and is regulated by miR-141
por: Xue, Lei, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ago6pikf3e4setcfk585tg4188